Table 4.
All n = 54 |
bTEVAR n = 25 (46.3%) |
hTEVAR n = 29 (53.7%) |
p-Value | |
---|---|---|---|---|
Aortic complication, n (%) | ||||
PND, n (%) | 0 | 0 | 0 | 1.00 |
RTAD, n (%) | 0 | 0 | 0 | 1.00 |
Aneurysm enlargement, n (%) | 0 | 0 | 0 | 1.00 |
Aneurysm rupture, n (%) | 2 (3.7) | 2 (8.0) *,+ | 0 | 0.210 |
Distal SINE, n (%) | 0 | 0 | 0 | 1.00 |
Prosthetic infection, n (%) | 2 (3.7) | 0 | 2 (6.9) | 0.493 |
Branched endograft occlusion, n (%) | 0 | 0 | 0 | 1.00 |
Bypass graft occlusion, n (%) | 0 | 0 | 0 | 1.00 |
Endoleaks, n (%) | ||||
Type 1a, n (%) | 0 | 0 | 0 | 1.00 |
Type 1b, n (%) | 1 (1.9) | 1 (4.0) * | 0 | 0.463 |
Type 1c, n (%) | 0 | 0 | 0 | 1.00 |
Type 2, n (%) | 0 | 0 | 0 | 1.00 |
Type 3, n (%) | 1 (1.9) | 1 (4.0) + | 0 | 0.463 |
bTEVAR; branched TEVAR; hTEVAR; hybrid TEVAR; TEVAR: thoracic endovascular aortic repair; PND: permanent neurological dysfunction; RTAD: retrograde type A dissection; SINE: stent graft-induced new entry, *: same patient, +: same patient.